SALIVARY GLAND TUMOURS: A REVIEW OF 91 CASES
Abstract
Background: Salivary gland tumours constitute heterogeneous group of tumours with different biological behaviour and account for 3% of all head and neck tumours. This study was conducted to study the clinico-pathological spectrum of salivary gland tumours. Methods: The study is a review of 91 cases of salivary gland tumours reported at Chugtai’s Lahore Laboratory from 2009-2011. The clinical data of the patients was obtained from their respective files. Results: Age range of the patients was from 8–92 years. These tumours were slightly more common in females with female to male ratio of 1.1:1. Parotid gland (51.6%) was the commonest site for the occurrence followed by minor salivary glands (27.4%). Majority (58.2%) of them were benign. Of all the benign and malignant tumours pleomorphic adenoma (47.2%) was commonest tumour followed by adenoid cystic (17.5%) and mucoepidermoid tumours (16.4%). Conclusion: These tumours are more common in females with wide range of age distribution. Parotid gland is the most common site of involvement with pleomorphic adenoma being the commonest tumour type.Keywords: Salivary gland tumours, pleomorphic adenoma, adenoid cystic carcinoma, mucoepidermoid carcinomaReferences
Arcuri F, Grivetto F, Poglio G, Brucoli M, Benech A: Simultaneous palatal pleomorphic adenoma and mandibular keratocystic odontogenic tumour in a pediatric patient. J Craniofac Surg 2011;22:2347–50.
Bell D, Hanna EY. Salivary Gland Cancers: Biology and Molecular Targets for Therapy. Curr Oncol Rep 2012;14:166–74.
Sarfraz T, Qureshi SM, Khan SS, Janjua OS, Alamgir W, Muhamma. Clinicopathological aspects of malignant salivary gland neoplasms – a study of 150 cases at AFIP, Rawalpindi (Pakistan). Pak Armed Forces Med J 2011;61:194–7.
Dyląg-Trojanowska K. Giant submandibular gland tumour: mucoepidermoid carcinoma within the pleomorphic adenoma (mixed tumour). Pol Przegl Chir 2011;83:227–30.
Arunkumar KV, Kumar S, Bansal V, Saxena S, Elhence P: Pleomorphic adenoma--unusual presentation of a salivary gland tumour in the neck of a child. Quintessence Int 2011;42:879–82.
Vuhahula EA. Salivary gland tumours in Uganda: clinical pathological study. Afr Health Sci 2004;4(1):15–23.
Speight PM, Barrett AW. Salivary gland tumours. Oral Dis 2002;8:229–40
Jones AV, Craig GT, Speight PM, Franklin CD. The range and demographics of salivary gland tumours diagnosed in a UK population. Oral Oncol 2008;44:407–17.
Gill MS, Muzaffar S, Soomro IN, Kayani N, Hussainy AS, Pervez S, et al. Morphological Pattern of Salivary Gland Tumours. J Pak Med Assoc 2001;51:343–6.
Gbotolorun OM, Arotiba GT, Effiom OA, Omitola OG. Minor salivary gland tumours in a Nigerian hospital: a retrospective review of 146 cases. Odontostomatol Trop 2008; 31(123):17–23.
Lopes MA, Kowalski LP, da Cunha Santos G, Paes de Almeida O. A clinicopathologic study of 196 intraoral minor salivary gland tumours. J Oral Pathol Med. 1999;28:264–7.
McHugh CH, Roberts DB, El-Naggar AK, Hanna EY, Garden AS, Kies MS, et al. Prognostic factors in mucoepidermoid carcinoma of the salivary glands. Cancer 2012;118:3928–36.
Rahman B, Mamoon N, Jamal S, Zaib N, Luqman M, Mushtaq S, et al. Malignant tumours of the minor salivary glands in northern Pakistan: a clinicopathological study. 2008;1(2):90–3.
Ladeinde AL, Adeyemo WL, Ogunlewe MO, Ajayi OF, Omitola OG. Salivary gland tumours: a 15-year review at the Dental Centre Lagos University Teaching Hospital. Afr J Med Med Sci. 2007;36:299–304
